A. John Rush, MD

Duke-National University of Singapore, Singapore; Corresponding Author: A. John Rush, MD, Duke-National University of Singapore, Graduate Medical School, 7 Avenida Vista Grande #112, Santa Fe, NM 87508 ([email protected]).

JCP
Can Our Collective Experiences As Clinicians Improve Mental Health Care?
Commentary

July 17, 2024

Drs Rush and Tramontin discuss how simple outcomes, often patient reported, could facilitate evidence-based decision making by clinicians, administrators, and payors and provide the foundation for a learning health...
A. John Rush, Tony Tramontin
JCP
A Comparison of 3 Scales for Measuring Adolescent Depression
Original Research

December 18, 2023

Three patient-reported outcomes—Patient Health Questionnaire for Adolescents, Quick Inventory of Depressive Symptomatology–Self-Report, and Very Quick Inventory of Depressive Symptomatology–Self-Report—can assess depressive symptom severity and change over time. Scores on...
Karabi Nandy, A. John Rush, Thomas Carmody, et al
PCC
New-Onset Psychosis After COVID-19 Vaccine
Case Report

November 15, 2022

A 45-year-old woman with no psychiatric history developed psychosis after receiving the COVID-19 vaccine. This report highlights that history of recent vaccine administration as a potential etiology deserves consideration...
Helene Alphonso, Dustin DeMoss, Cheryl Hurd, et al
JCP
In Memoriam: Jan Fawcett, MD
In Memoriam

July 11, 2022

A. John Rush and Steven D. Hollon reflect on Fawcett’s life and his contributions to the field, especially in the areas of treatment-resistant depression and suicide.
A. John Rush, Steven D. Hollon
JCP
Toward A Definition Of “No Meaningful Benefit” From Antidepressant Treatment
Original Research

June 27, 2022

The aim of this study was to develop and validate a categorical definition of “no meaningful benefit” from antidepressant treatment by equating percent change in scores on 3 common...
Carl Zhang, Sanya Virani, Taryn Mayes, et al
PCC
Case Report

January 6, 2022

Primary psychosis is the result of an underlying psychiatric disorder, while secondary psychosis is due to a medical cause. Here, the authors present a case of HHV-6 infection with...
Apoorva Deshpande, Zachary Herrmann, Jennifer Hsu, et al
JCP
Commentary

November 2, 2021

This commentary discusses therapeutic inertia--failure to (1) establish an optimal treatment dose to reach a desired outcome and (2) change treatment when a first treatment does not produce remission—in...
A. John Rush
PCC
Case Report

June 24, 2021

Diarrhea is a common side effect of divalproex sodium. Here, the authors present a geriatric case of divalproex sodium causing a high output despite numerous pharmacologic interventions.
Zachary Herrmann, Olla Elbasheer, Dustin DeMoss, et al
PCC
Case Report

October 15, 2020

This report describes the use of pramipexole to augment buprenorphine and antidepressant medications in a patient with depression and severe chronic back pain.
Rodrigo Escalona, Jan Fawcett, A. John Rush
JCP
Original Research

August 11, 2020

An antidepressant medication switch often follows a failed initial trial with SSRIs. This study sought to determine the probability and timing of both response and remission and the optimal...
A. John Rush, Charles South, Manish K. Jha, et al
JCP
Original Research

August 21, 2018

Vagus nerve stimulation (VNS) treatment has been shown to be efficacious in treatment-resistant depression (TRD). Can VNS treatment lead to improvements in quality of life in patients with TRD...
Charles R. Conway, Arun Kumar, Willa Xiong, et al
JCP
Original Research

August 24, 2016

Is your patient fully recovered from a major depressive episode? For some time the standard definition of MDE recovery has been eight weeks without significant symptoms. Discover the new...
Lewis L. Judd, Pamela J. Schettler, A. John Rush, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe